Biomarker Summit 2014


The Biomarker Summit 2014, to be held on March 19-21, 2014 in San Diego, CA is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization. A wide variety of important topics will be covered including biomarker identification and validation strategies, bioinformatics and systems biology approaches to personalized medicine, big data management, regulatory and reimbursement trends, companion diagnostics development, and, finally, funding and investment opportunities. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in three major therapeutic areas, formally organized in the following tracks and sessions:

7th Oncology Biomarkers:

  • Circulating Tumor Cells and Cell-Based Assays
  • Cell Free DNA and Blood-Based Assays
  • Imaging Biomarkers in Oncology
  • Digital & Molecular Pathology
  • Next Generation Sequencing in the Clinic
  • Applications of Mass Spectrometry Platforms

3rd Neurological Biomarkers:

  • Imaging in CNS Drug Discovery and Development
  • CSF / Fluid-based Biomarker Approaches
  • Early Identification and Preclinical Disease Biomarkers
  • EEG and Other Functional Biomarkers
  • Biomarker Development in Neuropsychiatric Disorders

3rd Inflammatory / Immunological Biomarkers:

  • Predicting Progression & Therapeutic Response of Cardiovascular Disease
  • Predictive Biomarkers of Slowly Progressive Diseases
  • Biomarkers and Surrogate Endpoints for Clinical Trials in Inflammatory Diseases
  • Immunological Biomarkers in Cancer Biomarker Challenges in Rare Diseases

General Session (All Tracks):

  • Bioinformatics & Biostatistics
  • Point of Care Testing
  • Panel Discussion: Regulatory & Reimbursement Trends in Biomarker Development
  • Panel Discussion: Investment Perspectives & Funding Opportunities
  • Panel Discussion: Companion Diagnostics Development & Partnering Strategies


  • Global Technology Community
  • 635 W. Foothill Blvd, Monrovia, CA 91016
  • phone: 626-256-6405
  • fax: 626-466-4433
  • email: [email protected]